PeptideScanner evidence for Maridebart cafraglutidehttps://peptidescanner.com/peptides/maridebart-cafraglutide/Versioned, source-linked PeptideScanner evidence objects for Maridebart cafraglutide. Selected coverage; not medical advice.en-usClinicalTrials.gov record NCT07575399https://peptidescanner.com/stories/clinicaltrials-gov-nct07575399-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07575399-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-08-27. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-09-09Clinical trialsLifecycle state: currentClinicalTrials.gov record NCT07684144https://peptidescanner.com/stories/clinicaltrials-gov-nct07684144-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07684144-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-09-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-09-09Clinical trialsLifecycle state: currentClinicalTrials.gov record NCT07313761https://peptidescanner.com/stories/clinicaltrials-gov-nct07313761-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07313761-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-08-07. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-08-14Clinical trialsLifecycle state: currentClinicalTrials.gov record NCT07684235https://peptidescanner.com/stories/clinicaltrials-gov-nct07684235-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07684235-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-08-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-08-14Clinical trialsLifecycle state: currentClinicalTrials.gov record NCT07037433https://peptidescanner.com/stories/clinicaltrials-gov-nct07037433-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07037433-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-07-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-08-13Clinical trialsLifecycle state: currentClinicalTrials.gov record NCT07037459https://peptidescanner.com/stories/clinicaltrials-gov-nct07037459-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07037459-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-07-02. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-08-13Clinical trialsLifecycle state: currentDesign and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.https://peptidescanner.com/stories/pubmed-pmid-42592044-maridebart-cafraglutide/urn:peptidescanner:story:pubmed-pmid-42592044-maridebart-cafraglutide:v1:currentLifecycle state current; Literature metadata; date in source 2026-08-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.2026-08-13Literature metadataLifecycle state: currentPubMed record PMID 41337722https://peptidescanner.com/stories/pubmed-pmid-41337722-maridebart-cafraglutide/urn:peptidescanner:story:pubmed-pmid-41337722-maridebart-cafraglutide:v1:currentLifecycle state current; Literature metadata; date in source 2026-03-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.2026-08-10Literature metadataLifecycle state: currentPubMed record PMID 41337723https://peptidescanner.com/stories/pubmed-pmid-41337723-maridebart-cafraglutide/urn:peptidescanner:story:pubmed-pmid-41337723-maridebart-cafraglutide:v1:currentLifecycle state current; Literature metadata; date in source 2026-03-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.2026-08-10Literature metadataLifecycle state: currentPubMed record PMID 41337724https://peptidescanner.com/stories/pubmed-pmid-41337724-maridebart-cafraglutide/urn:peptidescanner:story:pubmed-pmid-41337724-maridebart-cafraglutide:v1:currentLifecycle state current; Literature metadata; date in source 2025-12-03. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.2026-08-10Literature metadataLifecycle state: currentClinicalTrials.gov record NCT06987695https://peptidescanner.com/stories/clinicaltrials-gov-nct06987695-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct06987695-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2025-12-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-08-09Clinical trialsLifecycle state: currentClinicalTrials.gov record NCT07226765https://peptidescanner.com/stories/clinicaltrials-gov-nct07226765-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07226765-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-06-12. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-08-09Clinical trialsLifecycle state: currentClinicalTrials.gov record NCT07229157https://peptidescanner.com/stories/clinicaltrials-gov-nct07229157-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07229157-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-01-23. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-08-09Clinical trialsLifecycle state: currentClinicalTrials.gov record NCT07225686https://peptidescanner.com/stories/clinicaltrials-gov-nct07225686-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07225686-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-06-12. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-08-08Clinical trialsLifecycle state: currentClinicalTrials.gov record NCT07441252https://peptidescanner.com/stories/clinicaltrials-gov-nct07441252-maridebart-cafraglutide/urn:peptidescanner:story:clinicaltrials-gov-nct07441252-maridebart-cafraglutide:v1:currentLifecycle state current; Clinical trials; date in source 2026-06-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-08-08Clinical trialsLifecycle state: currentMariTide bioavailability study record updatedhttps://peptidescanner.com/stories/maritide-bioavailability-study-updated/urn:peptidescanner:story:maritide-bioavailability-study-updated:v1:currentLifecycle state current; Clinical trials; date in source 2026-07-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.2026-07-22Clinical trialsLifecycle state: current